Development and validation of chest CT-based imaging biomarkers for early stage COVID-19 screening

Xiao-Ping Liu,Xu Yang,Miao Xiong,Xuanyu Mao,Xiaoqing Jin,Zhiqiang Li,Shuang Zhou,Hang Chang
DOI: https://doi.org/10.3389/fpubh.2022.1004117
IF: 5.2
2022-09-22
Frontiers in Public Health
Abstract:Coronavirus Disease 2019 (COVID-19) is currently a global pandemic, and early screening is one of the key factors for COVID-19 control and treatment. Here, we developed and validated chest CT-based imaging biomarkers for COVID-19 patient screening from two independent hospitals with 419 patients. We identified the vasculature-like signals from CT images and found that, compared to healthy and community acquired pneumonia (CAP) patients, COVID-19 patients display a significantly higher abundance of these signals. Furthermore, unsupervised feature learning led to the discovery of clinical-relevant imaging biomarkers from the vasculature-like signals for accurate and sensitive COVID-19 screening that have been double-blindly validated in an independent hospital (sensitivity: 0.941, specificity: 0.920, AUC: 0.971, accuracy 0.931, F1 score: 0.929). Our findings could open a new avenue to assist screening of COVID-19 patients.
public, environmental & occupational health
What problem does this paper attempt to address?